HRAS and urinary bladder cancer: A slightly positive correlation (Pearson correlation: −0.366) between the sensitivity to a naturally occurring compound pterostilbene and HRAS expression was discovered in bladder carcinoma cell lines (Figure 1D and Figure S1), suggesting that bladder cancer cells with a higher expression level of HRAS might be sensitive to pterostilbene.